Analyzing the Swiss Market Index (SMI) from 2019 to 2024
The Swiss Market Index (SMI), a major stock market index representing Switzerland's 20 largest and most liquid stocks, has performed relatively well over the past five years, especially when compared with other global indices such as Germany’s DAX, the US’s S&P 500, South Korea’s KOSPI, and Japan’s Nikkei 225. Each of these indices provides valuable insights into global economic trends, market responses to key events, and sectoral shifts across major economies.
Foreword
This article delves into the performance of the SMI from 2019 to 2024, comparing it with major indices globally and identifying key stocks that have driven performance. Additionally, it provides a forecast for potential market movements, supported by statistics, and strategic recommendations for investors.
Understanding the SMI
This chapter provides a comprehensive guide for investors seeking to understand the Swiss Market Index. It explains key metrics for evaluating the SMI's performance, explores different investment strategies for accessing the index, and outlines the benefits and risks associated with investing in Swiss equities. It also provides practical tips for navigating the complex world of investing and making informed decisions regarding the SMI.
Swiss Market Index - SMI
12'037
+ 19.81%
5 Years
Overview of Swiss Market Index (SMI): 2019–2024
The Swiss Market Index (SMI) represents some of the most globally diversified and defensively positioned companies. Dominated by sectors such as pharmaceuticals (Novartis, Roche), consumer goods (Nestlé), and financial services (Credit Suisse, UBS), the index reflects the stability and resilience of the Swiss economy, particularly during periods of global uncertainty.
2019: Pre-Pandemic Growth
In 2019, the SMI was in a bullish phase, with consistent upward movement driven by strong corporate earnings and low interest rates globally. The index closed 2019 with a gain of approximately 26%, buoyed by stellar performances from pharmaceutical giants Roche and Novartis, as well as Nestlé, which benefited from growing consumer demand and product innovation.
2020: COVID-19 Impact and Recovery
The pandemic-induced market crash in March 2020 led to a steep sell-off, with the SMI losing 20% in value between February and March. However, the index rebounded quickly, outperforming many European counterparts, owing to the defensive nature of its key components. The healthcare sector, particularly Roche and Novartis, provided a buffer during the crisis as demand for medical supplies surged. Nestlé also benefited from increased demand for consumer staples as lockdowns drove stockpiling and shifts in consumer habits.
By the end of 2020, the SMI had largely recovered, posting a 3.82% annual gain, driven by the strength of the healthcare sector and Switzerland’s stable economic policies.
2021: Bullish Momentum Continues
In 2021, global markets continued to recover, and the SMI surged further, reaching an all-time high. The index closed 2021 with a gain of 20.3%, supported by strong earnings in the pharmaceutical sector as vaccine rollouts began and companies like Roche expanded their diagnostics business. Nestlé continued its strong performance, benefiting from the growing health-conscious consumer base and successful expansion into plant-based products.
2022 - A Year of Volatility and Resilience
The year 2022 was marked by global uncertainty stemming from geopolitical tensions, inflationary pressures, and tightening monetary policies. Despite these challenges, the SMI demonstrated remarkable resilience. Supported by its strong economic fundamentals and robust financial system, the index managed to navigate the choppy waters, showcasing its inherent stability. This chapter examines the key events that shaped the SMI's performance, analyzes the impact of global events on the Swiss economy, and highlights the role of key sectors within the index.
2023 - Navigating the Economic Headwinds
The year 2023 saw the continuation of global economic headwinds, with inflation remaining a concern and central banks cautiously navigating monetary policy. This chapter explores the impact of these factors on the SMI, analyzing potential scenarios and evaluating the resilience of Swiss companies in the face of these challenges. It examines the influence of emerging technologies, sustainability initiatives, and geopolitical developments on the index's trajectory.
2024 - A Year of Potential Growth and Opportunity
Looking ahead to 2024, the global economic landscape is expected to evolve with potential for increased growth and renewed investor confidence. This chapter explores the factors that could contribute to the SMI's potential growth, analyzing the role of innovation, technological advancements, and evolving consumer behaviors. It presents scenarios for the SMI's performance, highlighting opportunities and challenges that may arise.
Over 300 Ways to Make Money with GPT
24.90 €Lucrative Opportunities at Your Fingertips
Are you ready to explore a world of innovative income opportunities? Our comprehensive guideline document, “300+ Ways To Make Money With GPT,” is your essential resource for harnessing the power of AI to create diverse revenue streams from the comfort of your home.
Discover a wide array of income-generating ideas tailored to different skills and interests—from content creation and digital marketing to customer service automation and app development.
Maximize Your Earnings with over 300 methods included, you’ll find unique and lucrative ways to supplement your income or even establish a full-fledged business.
Download it today and start making money online with ease and flexibility.
Major Global Indices Analyzing Study with Germany, US, South Korea, and Japan
Germany (DAX):
Germany’s DAX followed a similar trend to the SMI but with greater volatility. After a steep drop in March 2020, the DAX recovered in the second half of the year, driven by the export sector and the global demand for industrial goods. However, the DAX faced greater challenges in 2022, as the energy crisis in Europe and supply chain disruptions weighed on the market.
- 2019: +25.5%
- 2020: +3.5%
- 2021: +15.8%
- 2022: -12.3% (decline due to inflation and the energy crisis)
- 2023: +8.9% (recovery phase)
United States (S&P 500):
The S&P 500, buoyed by the dominance of large-cap tech stocks, witnessed significant gains during the same period. The index faced a notable correction in 2022, as the Federal Reserve’s aggressive rate hikes aimed at curbing inflation led to a downturn in growth stocks.
- 2019: +28.9%
- 2020: +16.3%
- 2021: +26.9%
- 2022: -19.4% (inflation concerns and rate hikes)
- 2023: +12.2% (led by tech sector recovery)
South Korea (KOSPI):
The KOSPI is heavily influenced by the performance of tech and export-driven industries. After a strong rally in 2020 and 2021, the KOSPI underperformed in 2022 due to global supply chain disruptions and semiconductor shortages.
- 2019: +7.7%
- 2020: +30.8%
- 2021: +3.6%
- 2022: -24.9% (driven by the slowdown in the tech sector)
- 2023: +7.3% (moderate recovery)
Japan (Nikkei 225):
The Nikkei, while showing a positive trend in 2020 and 2021, struggled in 2022 due to rising commodity prices and a weak yen. The market's recovery was slower compared to Western counterparts due to ongoing concerns about global supply chains and inflationary pressures.
- 2019: +18.2%
- 2020: +16.0%
- 2021: +4.9%
- 2022: -9.4% (driven by energy price hikes and weak yen)
- 2023: +9.0% (partial recovery)
Statistical Overview of SMI’s Performance
- 2019: +26.0%
- 2020: +3.8%
- 2021: +20.3%
- 2022: -14.2% (global inflation and rate hikes)
- 2023: +9.5% (recovery following inflation slowdown)
Top Performers in the Swiss Market Index
(2019–2024)
Nestlé (Ticker: NESN.SW)
- Performance: One of the SMI’s largest components, Nestlé's stock has been a consistent performer over the last five years, returning 35% since 2019. The company capitalized on trends toward healthier eating and sustainability, launching several new product lines that resonate with modern consumers.
- Reason for Performance: Nestlé's diversification across sectors like health science and pet care, and its strong focus on sustainability, have attracted ESG-conscious investors.
Roche (Ticker: ROG.SW)
- Performance: Roche, one of the largest pharmaceutical companies globally, saw significant growth due to its diagnostics division, which benefited from the pandemic. Roche's stock appreciated by 42% from 2019 to 2024.
- Reason for Performance: Strong pipeline in oncology and significant contributions from the diagnostics business.
Top Laggards in the Swiss Market Index
(2019–2024)
Credit Suisse (Ticker: CSGN.SW)
- Performance: One of the worst-performing stocks in the SMI, Credit Suisse has been plagued by scandals and mismanagement, leading to a 50% decline in stock value from 2019 to 2024.
- Reason for Underperformance: Major losses related to the Archegos Capital and Greensill scandals, coupled with internal governance issues, have damaged investor confidence.
Swiss Re (Ticker: SREN.SW)
- Performance: Swiss Re underperformed during the period, posting modest gains of 12% over five years.
- Reason for Underperformance: The reinsurance sector has faced pressures from rising claims due to natural disasters and the pandemic, which affected profitability.
A Long-Term Perspective
Beyond the short-term outlook, the long-term future of SMI is tied to the continued success of the Swiss economy. Hence, technological innovation, the evolution of industry dynamics and the growing importance of sustainability are very important factors for the future of the market. The SMI is becoming more and more a market of long-term strategies and potentials than other leading global markets. Nevertheless, it remains an important reference for international and, logically, national investors.
SMI Stock List
Name | YTD |
UBS Group | -3.98% |
ABB | 0.2611 |
Logitech | -8.75% |
Holcim | 0.233 |
Alcon | 0.2687 |
Nestle | -10.16% |
Novartis | 0.1566 |
Swiss Re | 0.2251 |
Richemont | 0.041 |
Kuehne & Nagel | -14.22% |
Roche Holding Participation | 0.0863 |
Sika | -2.45% |
Sonova H Ag | 0.1079 |
Zurich Insurance Group | 0.1561 |
Geberit | 0.0045 |
Swisscom | 0.0899 |
Lonza Group | 0.5686 |
Swiss Life Holding | 0.1935 |
Partners Group | -1.57% |
Givaudan | 0.3065 |
CONCLUSION
The Swiss Market Index (SMI) has shown remarkable resilience from 2019 to 2024, driven by its defensive sectors like healthcare and consumer staples. While it has not been immune to global market volatility, its recovery has been faster and more consistent compared to other major indices. Stocks such as Nestlé and Roche have performed exceptionally well, while companies like Credit Suisse have struggled with internal issues.
For investors seeking stability in an uncertain global market, the SMI offers a compelling case for a hold or buy strategy. While the SMI may not offer the explosive growth seen in tech-heavy indices like the S&P 500, its steady performance makes it an attractive option for risk-averse investors looking for long-term gains.